GSK plc has announced that new drug applications have been accepted for review by the China National Medical Products ...
Zacks.com on MSN6d
EMA Accepts GSK's Filing for Depemokimab in Two Respiratory DiseasesGSK plc GSK recently announced that EMA has accepted the regulatory filing seeking approval for its IL-5 inhibitor ...
London: GSK plc has announced that the European Medicines Agency (EMA) has accepted for review the Marketing Authorisation Application for the use of depemokimab in two indications.The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback